June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Evaluation of Macular Ganglion Cell Layer Measurements Obtained Using a New Retinal Layer Segmentation Algorithm in Glaucoma Patients
Author Affiliations & Notes
  • Saif Baig
    Hamilton Glaucoma Center and Department of Ophthalmology, UC San Diego, San Diego, CA
  • Carolina Gracitelli
    Hamilton Glaucoma Center and Department of Ophthalmology, UC San Diego, San Diego, CA
    Department of Ophthalmology, Federal University of São Paulo, Sao Paulo, Brazil
  • Alberto Diniz-Filho
    Hamilton Glaucoma Center and Department of Ophthalmology, UC San Diego, San Diego, CA
    Department of Ophthalmology and Otorhinolaryngology, Federal University of Minas Gerais, Belo Horizonte, Brazil
  • Ricardo Y Abe
    Hamilton Glaucoma Center and Department of Ophthalmology, UC San Diego, San Diego, CA
    Department of Ophthalmology, University of Campinas, Campinas, Brazil
  • Linda M Zangwill
    Hamilton Glaucoma Center and Department of Ophthalmology, UC San Diego, San Diego, CA
  • Robert N Weinreb
    Hamilton Glaucoma Center and Department of Ophthalmology, UC San Diego, San Diego, CA
  • Felipe A Medeiros
    Hamilton Glaucoma Center and Department of Ophthalmology, UC San Diego, San Diego, CA
  • Footnotes
    Commercial Relationships Saif Baig, None; Carolina Gracitelli, None; Alberto Diniz-Filho, None; Ricardo Abe, None; Linda Zangwill, Carl Zeiss Meditec Inc (F), Heidelberg Engineering GmbH (F), Nidek Inc. (F), Optovue Inc. (F), Quark (F), Topcon Medical System Inc (F); Robert Weinreb, Aerie (F), Alcon (C), Allergan (C), Amatek (C), Aquesys (C), Bausch & Lomb (C), Carl Zeiss Meditec (C), Carl Zeiss Meditec (F), Genentech (F), Heidelberg Engineering GmbH (F), Nidek (F), Novartis (F), Optovue (F), Topcon (C), Topcon (F), Valeant (C); Felipe Medeiros, Alcon Laboratories Inc. (F), Alcon Laboratories Inc. (R), Allergan Inc. (F), Allergan Inc. (R), Bausch & Lomb (F), Carl Zeiss Meditec Inc. (F), Carl Zeiss Meditec Inc. (R), Heidelberg Engineering Inc. (F), National Eye Institute (F), Novartis (R), Reichert Inc. (F), Reichert Inc. (R), Sensimed (F), Topcon Inc. (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 4524. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Saif Baig, Carolina Gracitelli, Alberto Diniz-Filho, Ricardo Y Abe, Linda M Zangwill, Robert N Weinreb, Felipe A Medeiros; Evaluation of Macular Ganglion Cell Layer Measurements Obtained Using a New Retinal Layer Segmentation Algorithm in Glaucoma Patients. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):4524.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Using a novel segmentation algorithm, SD-OCT can now measure the thickness of the ganglion cell layer (GCL) independently from other retinal layers. The purpose of this study was to evaluate the ability of macular GCL thickness for glaucoma diagnosis and compare it to peripapillary retinal nerve fiber layer (RNFL) thickness.

Methods: A cross-sectional study was conducted including 278 eyes of 155 participants from the Diagnostic Innovations in Glaucoma Study. A total of 90 subjects had primary open angle glaucoma and 67 were healthy. Glaucoma was defined by the presence of repeatable abnormal standard automated perimetry (SAP) results and/or progressive glaucomatous optic disc change on masked grading of stereophotographs. All patients underwent spectral-domain optical coherence tomography imaging (Spectralis SD-OCT; Heidelberg Engineering, Heidelberg, Germany). Based on contrast differences between layers, a novel software algorithm allowed the SD-OCT to segment and measure macular GCL thickness independently from other macular layers. Areas under the receiver operating characteristic (ROC) curves were used to investigate the ability of each parameter in discriminating glaucomatous from healthy eyes. ROC curves were adjusted for age using a ROC regression model.<br />

Results: The mean±standard deviation (SD) age of participants was 60.1±16.8 years. The average SAP mean deviation in glaucoma eyes was -4.7 ± 5.7 dB. The global average GCL thickness in glaucomatous eyes was significantly lower than in healthy eyes (37.7±7.7 μm vs. 46.9±3.8 μm, respectively; P<0.001). Glaucomatous eyes also had thinner GCL thickness areas than healthy eyes in all quadrants. The average peripapillary RNFL thickness in glaucomatous eyes was 72.7±15.0 μm, which was significantly lower than the 100.4±9.1 μm in healthy eyes (P<0.001). There was strong correlation between global GCL thickness and RNFL thickness (R2 = 0.83; P < 0.001). Peripapillary RNFL thickness performed better than global GCL thickness in discriminating healthy and glaucomatous eyes with ROC curve areas of 0.91 and 0.72, respectively (P = 0.002).

Conclusions: Measurements of macular GCL thickness showed strong relationship with peripapillary RNFL thickness. However, peripapillary RNFL thickness still performed significantly better in discriminating glaucomatous from healthy eyes.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×